We are live on
!
Find out more
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX
Delisted
DBTX was delisted on the 22nd of September, 2023.
37 hedge funds and large institutions have $59.2M invested in Decibel Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
27% more capital invested
Capital invested by funds: $46.7M → $59.2M (+$12.6M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 38 → 37 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.58%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Neuberger Berman Group
New York
|
+$158K |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
+$154K |
| 3 |
B
Bailard
Foster City,
California
|
+$38.9K |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$36K |
| 5 |
BlackRock
New York
|
+$19.6K |
Top Sellers
| 1 |
Millennium Management
New York
|
-$320K |
| 2 |
NM
Newtyn Management
New York
|
-$197K |
| 3 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
-$59.7K |
| 4 |
Morgan Stanley
New York
|
-$35K |
| 5 |
JP Morgan Chase
New York
|
-$31.9K |
